CNSP stock

CNS Pharmaceuticals Inc (CNSP) financials · $6.6M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

CNS Pharmaceuticals Inc (CNSP) $6.6M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$16.0M-$14.9M
Net Income-$15.9M-$14.9M
EPS (Diluted)-$35.75-$38.87
Cached annual balance sheet
LineFY2025FY2024
Total Assets$8.62M$8.70M
Current Assets$8.10M$8.66M
Cash & Equivalents$7.20M$6.46M
PP&E$17.7K$6.00K
Total Liabilities$4.10M$2.52M
Current Liabilities$4.10M$2.52M
Shareholders' Equity$4.52M$6.18M
Retained Earnings-$100.3M-$84.4M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$13.8M-$17.1M
CapEx$18.2K$4.19K
Investing Cash Flow-$18.2K-$4.19K
Financing Cash Flow$14.6M$23.0M
Free Cash Flow-$13.8M-$17.1M
These statements as JSON? API free 100/day

FAQ

What is CNSP P/E and revenue?

CNS Pharmaceuticals Inc (CNSP) $6.6M cap.

What is CNSP revenue?

CNSP income-statement cache has no revenue figure yet.

Is CNSP profitable?

CNS Pharmaceuticals Inc last cached net income is -$15.9M (FY2025).

What are CNSP total assets?

CNS Pharmaceuticals Inc last cached total assets are $8.62M (FY2025).

What is CNSP free cash flow?

CNS Pharmaceuticals Inc last cached free cash flow is -$13.8M (FY2025).

Not investment advice. Cached statements, not a live tape.